A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282

Launched by ADDPHARMA INC. · Dec 19, 2024

Keywords

ClinConnect Summary

This clinical trial is designed to test the effectiveness and safety of two medications, AD-2281 and AD-2282, when taken together for patients with a condition called Primary Hypercholesterolemia, which means they have high cholesterol levels in their blood. The study aims to see if this combination can help lower cholesterol more effectively than other treatments. Currently, the trial is not yet recruiting participants.

To be eligible for this study, patients must be diagnosed with Primary Hypercholesterolemia and be willing to sign an informed consent, which means they agree to participate after understanding what the study involves. Patients with a different type of high cholesterol called Secondary Hypercholesterolemia will not be eligible. If you join the study, you will receive more information about what to expect during the trial, including any tests or visits you’ll need to complete. This trial is open to all adults, so if you or a family member are interested, keep an eye out for when recruitment begins.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Signed informed consent
• • Patients with Primary Hypercholesterolemia
• • Other inclusions applied
• Exclusion Criteria:
• • Patients with Secondary Hypercholesterolemia
• • Other exclusions applied